India - English - Central Drugs Standard Control Organization

bonsai ph. - cap - 10

Ireland - English - HPRA (Health Products Regulatory Authority)

janssen biologics b.v. -

New Zealand - English - Medsafe (Medicines Safety Authority)

health consulting group ltd - nebacumab 5 mg/ml - solution for injection - 100mg/20ml - active: nebacumab 5 mg/ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - digoxin - tablet - 250 mcg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

opsonin pharma limited - digoxin - elixir - 5 mg/100 ml

European Union - English - EMA (European Medicines Agency)

intervet international b.v - fluralaner - ectoparasiticides for systemic use, isoxazolines - dogs; cats - dogs:- for the treatment of tick and flea infestations;the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).- for the treatment of demodicosis caused by demodex canis;- for the treatment of sarcoptic mange (sarcoptes scabiei var. canis) infestation.- for reduction of the risk of infection with babesia canis canis via transmission by dermacentor reticulatus. [chewable tablets only]cats:- for the treatment of tick and flea infestations;the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).- for the treatment of infestations with ear mites (otodectes cynotis).

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

helianthus annus 65%,rosa canina l. 22.2%,borapo officinalis 11.1%,melaleuca altenifolia flos 0.34%,bergamottae flos 0.34%,cymbogoginis nardi herbal 0.34%,syzginum aromaticum 0.34%

European Union - English - EMA (European Medicines Agency)

merial - fipronil, amitraz, (s)-methoprene - ectoparasiticides for topical use, incl. insecticides - dogs - treatment and prevention of infestations in dogs by ticks (ixodes ricinus, dermacentor reticulatus, rhipicephalus sanguineus, ixodes scapularis, dermacentor variabilis, haemaphysalis elliptica, haemaphysalis longicornis, amblyomma americanum and amblyomma maculatum) and fleas (ctenocephalides felis and ctenocephalides canis). treatment of infestations by chewing lice (trichodectes canis). prevention of environmental flea contamination by inhibiting the development of all flea immature stages. the product can be used as part of a treatment strategy for the control of flea-allergy dermatitis. elimination of fleas and ticks within 24 hours. one treatment prevents further infestations for five weeks by ticks and for up to five weeks by fleas.the treatment indirectly reduces the risk of transmission of tick-borne diseases (canine babesiosis, monocytic ehrlichiosis, granulocytic anaplasmosis and borreliosis) from infected ticks for four weeks.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner - isoxazolines, ectoparasiticides for systemic use - dogs - treatment of flea infestation in dogs (ctenocephalides felis and c. canis)  for at least 5 weeks. the product can be used as part of a treatment strategy for the control of flea allergy dermatitis (fad).treatment of tick infestation in dogs (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus). one treatment kills ticks for up to one month.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance. treatment of demodicosis (caused by demodex canis).treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis).

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - afoxolaner, milbemycin oxime - endectocides, antiparasitic products, insecticides and repellents, milbemycin oxime, combinations - dogs - for the treatment of flea and tick infestations in dogs when the concurrent prevention of heartworm disease (dirofilaria immitis larvae), angiostrongylosis (reduction in level of immature adults (l5) and adults of angiostrongylus vasorum), thelaziosis (adult thelazia callipaeda) and/or treatment of gastrointestinal nematode infestations is indicated.treatment of flea infestations (ctenocephalides felis and c. canis) in dogs for 5 weeks. treatment of tick infestations (dermacentor reticulatus, ixodes ricinus, ixodes hexagonus, rhipicephalus sanguineus) in dogs for 4 weeks.fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.treatment of infestations with adult gastrointestinal nematodes of the following species: roundworms (toxocara canis and toxascaris leonina), hookworms (ancylostoma caninum, ancylostoma braziliense and ancylostoma ceylanicum) and whipworm (trichuris vulpis). treatment of demodicosis (caused by demodex canis). treatment of sarcoptic mange (caused by sarcoptes scabiei var. canis). prevention of heartworm disease (dirofilaria immitis larvae) with monthly administration. prevention of angiostrongylosis (by reduction of the level of infection with immature adult (l5) and adult stages of angiostrongylus vasorum) with monthly administration.prevention of establishment of thelaziosis (adult thelazia callipaeda eyeworm infection) with monthly administration.